Previous 10 | Next 10 |
SUNNYVALE, Calif., Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular disorders, is targeting heart failure and chron...
SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, issues the following letter to shareholders: Dear Shareholders, BioCardia completed 20...
SUNNYVALE, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced that the first patient was enrolled and treated in its CardiALLO...
SUNNYVALE, Calif., Dec. 18, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that Japan Pharmaceutical and Medical Device Agency (PMDA) minutes support the...
SUNNYVALE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today provided an update after its recent consultation with Japan’s Pharmaceutical and ...
2023-11-16 13:09:06 ET More on BioCardia BioCardia doesn't see Phase 3 study meeting primary endpoint, stock slides Seeking Alpha’s Quant Rating on BioCardia Historical earnings data for BioCardia For further details see: BioCardia's shares fall on...
SUNNYVALE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA] (the “Company”), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that it has entered into a definitive agreement...
2023-11-15 08:24:52 ET Graphite Bio GRPH -15% following reverse merger with LENZ Therapeutics in all-stock deal . Global E Online GLBE -15% on Q3 earnings release . Tivic Health Systems TIVC -15% on Q3 earnings release . reAlpha Tech ( AIRE ) -14%...
2023-11-14 14:22:16 ET Gainers: BioCardia ( BCDA ) +170% . reAlpha Tech Corp. ( AIRE ) +119% . Turnstone Biologics Corp ( TSBX ) +75% . Theseus Pharmaceuticals ( THRX ) +49% . American Coastal Insurance Corp ( ACIC ) +38% . M...
2023-11-14 10:00:40 ET DENVER, Colo., Nov. 14, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioCardia Inc (NASDAQ: BCDA), INVO Bioscience Inc (NASDAQ: INVO), Theseus Pharmaceuticals Inc (NASDAQ: THRX),...
News, Short Squeeze, Breakout and More Instantly...
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the Unites States Patent Office has granted Patent No: 12,036,371 ti...
SUNNYVALE, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the Unites States Patent Office has granted Patent No: ...